Phase I trial of three-weekly docetaxel, carboplatin and oral lenalidomide (Revlimid) in patients with advanced solid tumors. [electronic resource]
Producer: 20070730Description: 211-6 p. digitalISSN:- 0167-6997
- Administration, Oral
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carboplatin -- administration & dosage
- Docetaxel
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Humans
- Infusions, Intravenous
- Lenalidomide
- Male
- Maximum Tolerated Dose
- Middle Aged
- Neoplasms -- drug therapy
- Taxoids -- administration & dosage
- Thalidomide -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article
There are no comments on this title.
Log in to your account to post a comment.